Yasuyuki Kobayashi MD, PhD, Presenter: Nothing to Disclose

Hitomi Kobayashi MD, Abstract Co-Author: Nothing to Disclose

Masaharu Hirano MD, Abstract Co-Author: Nothing to Disclose

Yukihisa Ogawa, Abstract Co-Author: Nothing to Disclose

Isamu Yokoe, Abstract Co-Author: Nothing to Disclose

Yasuo Nakajima MD, Abstract Co-Author: Nothing to Disclose

The purpose of this exhibit is: 1. To review the clinical cardiac involvements and typical pathophysiological findings in rheumatic diseases. 2. To demonstrate cardiac MRI findings in the patients of rheumatic diseases with and without cardiac symptoms. 3. To discuss the role of cardiac MRI to monitor the biological drug therapy in rheumatic diseases.  

Role of cardiac MRI, compared with MDCT, US and RI in Rheumatic Diseases - Cine MRI and Tagging MRI - LV Geometry (LV Mass and Mass/EDV) - Stress/Rest Perfusion MRI - Delayed Enhanced MRI - Coronary CTA and MRA - US - RI Cardiac Involvement in Rheumatic Diseases - Systemic Sclerosis - Systemic Lupus Erythematosus - Rheumatoid Arthritis - Polymyositis / Dermatomyositis - Periarteritis nodosa - MCTD - Others Monitoring of the Biologics Therapy in Rheumatoid Arthritis.    

http://abstract.rsna.org/uploads/2014/14015930/14015930_7kyf.pdf

Kobayashi, Y, Kobayashi, H, Hirano, M, Ogawa, Y, Yokoe, I, Nakajima, Y, Cardiac MRI for the Diagnosis and Monitoring of Cardiac Involvements in Rheumatic Diseases.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14015930.html